SUBJECT: STRATEGIC MANAGEMENT
SUBJECT CODE: MGT6303
NAME: HARMEET SINGH KANG ID NO: SCM–027416 (MFP/2014-05)
TABLE OF CONTENTS
INDEX PAGE NO.
Executive Summary………………………………………………………….……………………4
Section 1
CIPLA (Pharmaceutical Company)
Introduction…………………………………………………………………..……………………5
Section 2
PESTLE ANALYSIS
2.1 Political and Legal factors……...………………………..…………………………………....7
2.2 Economical factors…………………………………………………………………………....8
2.3 Social-cultural factors………….………………………………………………………….......8
2.4 Technological factors………….………………………………………………………….......8
2.5 Environment factors…………………………………………………………………………..9
Section 3
SWOT ANALYSIS
3.1Strength……………………………………………………………………………………….10
3.2 Weaknesses…………………………………………………………………………………..11
3.3 Opportunities………………………………………………………………………………...11
3.4 Threats……………………………………………………………………………………….12
Section 4
Porter’s Five Forces Analysis
4.1 Buyer power is low………………………………………………………………………….14
4.2 Supplier power is low……………………………………………………………………….14
4.3 Threats of new entrance…………………………………………………………………….14
4.4 Threats of substitute products………………………………………………………………15
4.5 Rivalry among existing firm’s………………………………………………………………15
Conclusion………………………………………………………………………………………16
Recommendation……………………………………………………………………………….16
References………………………………………….……………………………………………17
EXECUTIVE SUMMARY
This report examines an Indian pharmaceutical industry has a have biggest impact on Cipla in its operating environment, i made a comprehensive analysis Cipla with three analyzing tool, that is PESTEL, SWOT and Porter Five Forces. Starting with PESTEL analysis, political is not the advantage for Cipla, excepting those policy I mentioned in essay, free market index is very low in India.Significant socio-cultural trends identified by the report are
References: 4. Michael Porter, 1979, Competitive Strategy. New York: The Free Press.